North America Infant, Child, and Maternal Probiotic Supplements Market Forecast to 2028 - COVID-19 Impact and Regional Analysis

Description

List of Tables

The North America infant, child, and maternal probiotic supplements market is expected to grow from US$ 237.56 million in 2022 to US$ 386.82 million by 2028; it is estimated to grow at a CAGR of 8.5% from 2022 to 2028.

According to the World Health Organization (WHO), providing proper nutrition to babies in their first three years can reduce mortality and morbidity, decrease the risk of chronic diseases throughout their lifetime, and promote regular mental and physical growth. The poor nutrition of infants can cause serious health issues, including stunted growth and malnutrition. Additionally, poor nutrition during the first three months of a baby's life can increase the risk of death. However, the rising awareness of proper infant nutrition among parents has reduced the infant mortality rate. According to the Centers for Disease Control and Prevention (CDC), the infant mortality rate in the US in 2020 was 5.4 deaths per 1,000 live births.

Due to the benefits of infant and child probiotic supplements, it has also gained immense traction among parents. Probiotics help relieve acute constipation, acid reflux, and colic in healthy infants and children. Moreover, probiotics help build a strong barrier against distress, causing bacteria in the gastrointestinal (GI) tract of infants and children, improving their immunity and digestive health. Probiotic supplements also help in preventing children from eczema and other allergies. Parents are increasingly seeking supplements infused with probiotics to support a range of health requirements for their children. According to a survey conducted by Fonterra Co-operative Group Limited and Euromonitor, 52% of the surveyed population stated that digestive health is the primary reason for giving probiotic vitamins and supplements to their children, while 41% voted for general health and 38% voted for immune health. Thus, the rising importance of specific nutrition for children's proper development and well-being and the increasing demand for probiotic supplements in pediatric nutrition are the key factors driving the infant, child, and maternal probiotic supplements market growth.

With new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America infant, child, and maternal probiotic supplements market growth at a notable CAGR during the forecast period.

North America Infant, Child, and Maternal Probiotic Supplements Market Revenue and Forecast to 2028 (US$ Million)

North America Infant, Child, and Maternal Probiotic Supplements Market Segmentation

The market for North America infant, child, and maternal probiotic supplements market is segmented into form, end user, and country. Based on form, the market is categorized into capsules and soft gels, gummies, liquid, and others. Based on end user, the market is segmented into infant and toddler, children, and maternal women. Based on country, the North America infant, child, and maternal probiotic supplements market is segmented into the US, Canada, and Mexico.

North America Infant, Child, and Maternal Probiotic Supplements Market - Companies Mentioned

Bayer Corporation; MaryRuth Organics, LLC; Mommy's Bliss Inc.; Pharmavite LLC; Nestle S.A.; BioGaia AB; Evolve Biosystems; Lovebug Probiotics; Biomeology; and Nordic Naturals are a few major companies operating in the North America infant, child, and maternal probiotic supplements market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Infant, Child, and Maternal Probiotic Supplements Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in North America Infant, Child, and Maternal Probiotic Supplements Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Product Code: BMIRE00027153

1. Introduction

1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation

2. Key Takeaways

3. Research Methodology

3.1 Scope of the Study
3.2 Research Methodology
- 3.2.1 Data Collection:
- 3.2.2 Primary Interviews:
- 3.2.3 Hypothesis Formulation:
- 3.2.4 Macro-economic Factor Analysis:
- 3.2.5 Developing Base Number:
- 3.2.6 Data Triangulation:
- 3.2.7 Country Level Data:
- 3.2.8 Limitations and Assumptions:

4. North America Infant, Child, and Maternal Probiotic Supplements Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Expert Opinion
4.4 Ecosystem Analysis

5. North America Infant, Child, and Maternal Probiotic Supplements Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Demand for Probiotic Supplements in Paediatric Nutrition
- 5.1.2 Growing Awareness Regarding Benefits of Probiotic Supplements among Pregnant Women
5.2 Market Restraints
- 5.2.1 Consumer Perceptions on Probiotic Supplements for Newburn
5.3 Market Opportunities
- 5.3.1 Surging Demand in Developing Regions
5.4 Future Trends
- 5.4.1 Increasing Research and Development in Infant and Maternal Probiotics Space
5.5 Impact Analysis of Drivers and Restraints

6. Infant, Child, and Maternal Probiotic Supplements - Market Analysis

6.1 North America Infant, Child, and Maternal Probiotic Supplements Market -Revenue and Forecast to 2028 (US$ Thousand)

7. North America Infant, Child, And Maternal Probiotic Supplements Market Analysis - By Form

7.1 Overview
7.2 North America Infant, Child, And Maternal Probiotic Supplements Market, By Form (2021 and 2028)
7.3 Capsules and Softgels
- 7.3.1 Overview
- 7.3.2 Capsules and Softgels: North America Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
7.4 Gummies
- 7.4.1 Overview
- 7.4.2 Gummies: North America Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
7.5 Liquid:
- 7.5.1 Overview
- 7.5.2 Liquid: North America Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: North America Infant, Child, And Maternal Probiotic Supplements Market- Revenue and Forecast to 2028 (US$ Thousand)

8. North America Infant, Child, And Maternal Probiotic Supplements Market Analysis - By End User

8.1 Overview
8.2 North America Infant, Child, And Maternal Probiotic Supplements Market, By End User (2021 and 2028)
8.3 Infant and Toddler
- 8.3.1 Overview
- 8.3.2 Infant and Toddler: North America Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
8.4 Children
- 8.4.1 Overview
- 8.4.2 Children: North America Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
8.5 Maternal Women
- 8.5.1 Overview
- 8.5.2 Maternal Women: North America Infant, Child, And Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)

9. North America Infant, Child, and Maternal Probiotic Supplements Market - Country Analysis

9.1 North America: North America Infant, Child, and Maternal Probiotic Supplements Market
- 9.1.1 North America: North America Infant, Child, and Maternal Probiotic Supplements Market -Revenue and Forecast to 2028 (US$ Thousand)
- 9.1.2 North America: North America Infant, Child, and Maternal Probiotic Supplements Market, by Key Country
  - 9.1.2.1 US: North America Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 9.1.2.1.1 US: North America Infant, Child, and Maternal Probiotic Supplements Market, By Form
    - 9.1.2.1.2 US: North America Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.1.2.2 Canada: North America Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 9.1.2.2.1 Canada: North America Infant, Child, and Maternal Probiotic Supplements Market, By Form
    - 9.1.2.2.2 Canada: North America Infant, Child, and Maternal Probiotic Supplements Market, by End User
  - 9.1.2.3 Mexico: North America Infant, Child, and Maternal Probiotic Supplements Market - Revenue and Forecast to 2028 (US$ Thousand)
    - 9.1.2.3.1 Mexico: North America Infant, Child, and Maternal Probiotic Supplements Market, By Form
    - 9.1.2.3.2 Mexico: North America Infant, Child, and Maternal Probiotic Supplements Market, by End User

10. Industry Landscape

10.1 Overview
10.2 Product launch
10.3 Expansion

11. Company Profiles

11.1 Bayer Corporation
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 MaryRuth Organics, LLC
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Mommy's Bliss Inc.
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Pharmavite LLC
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Nestle S.A.
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 BioGaia AB
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Evolve Biosystems
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Lovebug Probiotics
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 Biomeology
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 Nordic Naturals
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Word Index